Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 15,000,000
    Countries
    Sector(s)
    France : € 15,000,000
    Services : € 15,000,000
    Signature date(s)
    21/07/2021 : € 7,500,000
    21/07/2021 : € 7,500,000
    Link to source
    Data sheet

    Summary sheet

    Release date
    31 October 2023
    Status
    Reference
    Signed | 21/07/2021
    20200330
    Project name
    Promoter - financial intermediary
    SURGIVISIO (EGFF)
    ECENTIAL ROBOTICS SAS
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 15 million
    EUR 40 million
    Location
    Sector(s)
    • Services - Professional, scientific and technical activities
    Description
    Objectives

    The promoter is a French commercial stage innovative medical device company that designs and develops a robotic platform to assist surgeons in performing complex surgical procedures in a minimally invasive manner. The company successfully developed a fully integrated device for spine surgery, which consists in an imaging device and a navigation system, and is now focusing its efforts on adding a robotic arm to the platform and on leveraging its versatility to target new indications. The project includes: (i) the combination of the already marketed 3D imaging solution with a third party robotic arm; (ii) the regulatory approval (CE mark and FDA approval) of the unified 3D imaging and robotic system in spine surgery; (iii) the expansion of the range of applications of the robotic solution and (iv) the development of the next generation of the device.

    By improving and commercialising the company's product, the project will foster the company's growth and create new jobs in the EU. Additionally, the project and all its research, development and innovation (R&D) activities, will contribute to the competitive search and generation of new knowledge across Europe in areas that are key to improve citizens' health.

    Environmental aspects
    Procurement

    The activities to be financed are R&D in the medical technology sector, enabling the company to develop its robotic surgery products. Due to the project's characteristics, the project does not fall under Annex I or Annex II of the Environmental Impact Assessment (EIA) Directive 2014/52/EU amending Directive 2011/92/EU.

    The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not covered by EU directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The EIB's services verified details during the project due diligence.

    Milestone
    Under appraisal
    Approved
    Signed
    18 December 2020
    21 July 2021
    Link to source
    Summary sheet

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - SURGIVISIO (EGFF)
    Publication Date
    8 Nov 2023
    Document language
    Main Topic
    Lending
    Document Number
    135712897
    Document Focus
    Environmental Information
    Project Number
    20200330
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now
    scoreboard - EUROPEAN GROWTH FINANCE FACILITY
    Publication Date
    13 Sep 2019
    Document Language
    English
    Main Topic
    lending
    Document Number
    122912044
    Document Focus
    EFSI legal requirements
    Document Type
    Scoreboard
    Project Number
    20180667
    Last update
    19 Aug 2020
    Sector(s)
    Services
    Countries
    Bulgaria, Kenya, Ghana, Mexico, Philippines
    Publicly available
    Download now

    News & Stories

    Photogallery

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications